Quick Summary — TGTX scores higher on quality with 8.6/10 vs TIL's 4.4/10. TGTX trades at $36.64 while TIL trades at $8.11. Both analyzed daily using SEC EDGAR data across 13 institutional models.
TGTX scores higher with a 8.6/10 quality rating vs TIL's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $36.64, TGTX trades +57.5% above its Bayesian DCF fair value of $15.58, while TIL at $8.11 trades +68.9% above its estimate of $2.52. TIL shows a wider gap between price and intrinsic value.
TGTX earns a Quality of Company score of 8.6/10 compared to TIL's 4.4/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
TGTX carries a SAFE value trap risk (6/100) while TIL shows SAFE risk (24/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.
Both TGTX and TIL operate in Biotechnology, which has 566 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare TGTX vs TIL differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.